ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a m... ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever. 더 보기
ProtoKinetix Upgrades to OTCQB PR Newswire ST. MARYS, W.Va., June 8, 2015 ST. MARYS, W.Va., June 8, 2015 /PRNewswire/ -- ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix...
ProtoKinetix, Incorporated (OTC: PKTX) (www.protokinetix.com) (“ProtoKinetix” or the “Company”) is pleased to announce that it has completed the acquisition of a portion of certain patents...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0026 | 32.5 | 0.008 | 0.0106 | 0.008 | 149920 | 0.00995811 | CS |
4 | 0.00073 | 7.39614994934 | 0.00987 | 0.011 | 0.008 | 117277 | 0.00989535 | CS |
12 | 0.00015 | 1.43540669856 | 0.01045 | 0.0125 | 0.008 | 131608 | 0.01002225 | CS |
26 | 0.0005 | 4.9504950495 | 0.0101 | 0.0142 | 0.008 | 105989 | 0.0102588 | CS |
52 | -0.0034 | -24.2857142857 | 0.014 | 0.021 | 0.008 | 113853 | 0.01264979 | CS |
156 | -0.0646 | -85.9042553191 | 0.0752 | 0.0832 | 0.008 | 99545 | 0.02610872 | CS |
260 | -0.1244 | -92.1481481481 | 0.135 | 0.27 | 0.008 | 88563 | 0.06841096 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관